Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) will be announcing its earnings results after the market closes on Monday, November 11th. Analysts expect the company to announce earnings of $0.57 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last announced its earnings results on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.01. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. The business had revenue of $48.95 million for the quarter, compared to analysts’ expectations of $48.05 million. During the same period last year, the firm posted $0.56 earnings per share. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Crescent Capital BDC Price Performance
NASDAQ CCAP opened at $18.30 on Friday. The company has a 50-day moving average price of $18.39 and a 200-day moving average price of $18.36. Crescent Capital BDC has a 52 week low of $15.91 and a 52 week high of $19.63. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of $678.20 million, a P/E ratio of 6.65 and a beta of 0.81.
Crescent Capital BDC Increases Dividend
Analysts Set New Price Targets
CCAP has been the topic of several analyst reports. Wells Fargo & Company dropped their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 14th. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 target price on the stock. Finally, Bank of America cut their price target on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 15th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $19.00.
Read Our Latest Research Report on CCAP
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Read More
- Five stocks we like better than Crescent Capital BDC
- How to Evaluate a Stock Before Buying
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- 3 REITs to Buy and Hold for the Long Term
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- The 3 Best Retail Stocks to Shop for in August
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.